Author’s Reply to Joerg Putzke et al. Comment on: “Safety of Marketed Cancer Supportive Care Biosimilars in the US: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database”
- 16 April 2021
- journal article
- letter
- Published by Springer Nature in BioDrugs
- Vol. 35 (3) , 375-377
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Author’s Reply to Joerg Putzke et al. Comment on: “Safety of Marketed Cancer Supportive Care Biosimilars in the US: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database”BioDrugs, 2021
- Comment on: “Safety of Marketed Cancer Supportive Care Biosimilars in the U.S.: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database”BioDrugs, 2021
- Safety of Marketed Cancer Supportive Care Biosimilars in the US: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) DatabaseBioDrugs, 2021
- Post-Marketing Safety Concerns with Esketamine: A Disproportionality Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting SystemPsychotherapy and Psychosomatics, 2020
- Assessment of factors associated with completeness of spontaneous adverse event reporting in the United States: A comparison between consumer reports and healthcare professional reportsJournal of Clinical Pharmacy and Therapeutics, 2019
- Significance of data mining in routine signal detection: Analysis based on the safety signals identified by the FDAPharmacoepidemiology and Drug Safety, 2018
- Applying quantitative methods for detecting new drug safety signals in pharmacovigilance national databasePharmacoepidemiology and Drug Safety, 2007
- Data-mining analyses of pharmacovigilance signals in relation to relevant comparison drugsEuropean Journal of Clinical Pharmacology, 2002
- On the assessment of adverse drug reactions from spontaneous reporting systems: the influence of under‐reporting on odds ratiosStatistics in Medicine, 2002